Over the last five decades, emphasis in mechanical ventilation has increasingly focused on improving oxygenation, while avoiding iatrogenic complications. Although carbon dioxide measurements are used to guide ventilatory adequacy, most ventilatory strategies are aimed primarily at adequate oxygenation. Measurements and indices of oxygenation, such as Pa O 2 , Sp O 2 , and Pa O 2 /FI O 2 or A -a (alveolar-arterial) gradients are frequently utilized to adjust ventilatory settings and aid in clinical decision-making. 1 -4 Although attention is paid to minute ventilation, ventilatory frequency, tidal volumes, and Pa CO 2 , there is no common unifying index that can be easily used to assess the efficacy of CO 2 elimination at the bedside. Especially in an era where permissive hypercapnia is widely practiced, 5 the development of such an index becomes evermore crucial.
Clinical problems with CO 2 elimination will be manifest as an elevation in Pa CO 2 , a requirement for increased minute ventilation, or a combination of both. The ideal index reflecting CO 2 elimination would need to be simple to use and easily repeatable. We use the ratio of the product of measured _ V E and Pa CO 2 to predicted values of the same parameters to derive a novel index called ventilatory ratio (VR). We present the physiological analysis of VR, followed by a description of the calculation and rationale of the predicted values. Outlined below is the theoretical description of VR, an index we believe in time will be shown to have a wide range of clinical applications.
Methods

Physiological analysis
We define the VR as
At steady state, carbon dioxide production and alveolar ventilation are the determinants of Pa CO 2 . Alveolar ventilation is a variable fraction of minute ventilation (about two-thirds in fit unanaesthetized individuals), the remaining fraction being physiological deadspace ventilation.
VR can be analysed in terms of carbon dioxide production and the fraction of minute ventilation that is alveolar ventilation, as follows. First
and
Therefore, equation (3) may be substituted into equation (2) and rearranged as
Assuming,
Equation (5) may be restated for Pa CO 2 Pa
This is a restatement of standard concepts in respiratory physiology. [We will discuss the validity of the assumption in equation (5) later.] Secondly, it is helpful to have a way of speaking about alveolar ventilation as a fraction of minute ventilation. We call this the 'ventilatory efficiency', E
From which
Equation (9) demonstrates the relationship of ventilatory efficiency to the more usually considered deadspace ventilation
although the right-hand side of equation (9) is not required for our purposes. Thirdly, the concept of 'actual' and 'predicted' carbon dioxide production and ventilatory efficiency is required. Measured minute ventilation and arterial carbon dioxide will be dependent upon actual carbon dioxide production and ventilatory efficiency. Equations (6) and (8) can be applied to these concepts as follows
Finally, the right-hand sides of the two pairs of equations (10) and (11) are substituted into equation (1), the definition of VR, which results
. This is more conveniently rearranged to give
Calculation of predicted values
In order to calculate VR, we must first calculate the predicted values.
For the predicted value of minute ventilation, we are using 100 ml kg 21 min
21
. This value is extracted from population nomograms from anaesthesic practice.
For predicted body weight (PBW), we have used the ARDSnet PBW calculator. PBW (kg) is calculated using the formula 50+0.91 (centimetres of height-152.4) for males, and 45.5+0.91 (centimetres of height-152.4) for females. 8 The predicted value used for Pa CO 2 is 5 kPa. Because the range of Pa CO 2 values in healthy individuals is narrow, we have used a value that lies close to the mean to represent the predicted Pa CO 2 .
For clinical application at the bedside, VR can be restated in a user-friendly form by the insertion of the above-mentioned predicted values into equation (1) VR
VR in the clinical setting
In order to derive an impression of the range of values of VR, a retrospective analysis of intensive care unit (ICU) and anaesthetic charts was carried out to calculate the VR in 100 mechanically ventilated patients. Ninety-two of the patients were admitted to the ICU and eight patients were perioperative patients. For ICU patients, VR was calculated twice a day during the course of ICU admission, and for perioperative patients, a single VR value was calculated. For the purposes of analysis, we have used a single value of VR per patient, this was the highest recorded VR value. Co-variate analysis was carried out using the MannWhitney U-test.
Results
Inspection of equation (13) shows that VR is governed by carbon dioxide production and ventilatory efficiency in a logically intuitive way. VR is a dimensionless numerical value. Where predicted values match actual values, as in normal individuals, the range of VR will be distributed around unity. When considering dynamic changes, an increasing VR represents increasing carbon dioxide production, decreasing ventilatory efficiency, or both. Conversely a decreasing VR represents decreasing carbon dioxide production, increasing ventilatory efficiency, or both. Provided the other variable remains constant, VR has a linear relationship with both Pa CO 2 and _ V E . Similarly, VR would have a linear relationship to ventilatory frequency and tidal volume, provided the other variable remains constant. As the ratio is dependent on minute ventilation and Pa CO 2 , any alterations in ventilatory settings that result in a change in VR would either be due to changes in alveolar ventilation or a significant change in the CO 2 production. Figure 1 shows the hyperbolic relationship of minute ventilation and Pa CO 2 , for given values of VR.
Outlined below is a brief summary of the findings from the patients. As anticipated, there is a wide range of values of VR in ICU patients.
The range of VR was 0.536 -5.222 [median 1.674, inter-quartile range (IQR) 1.277 -2.364] for all patients.
For ICU patients, the range was 0.776 -5.222 (median 1.762, IQR 1.438 -2.382). The range for perioperative patients was 0.54 -1.04 (median 0.84, IQR 0.73-0.945). The differences between the two groups are illustrated in Figure 2 ; it is anticipated that the VR values of the perioperative group represent 'normal values'.
As shown in Table 1 , there was no significant difference in VR between age, sex, and smokers. Patients with a respiratory cause for their admission or those patients who developed ventilator-associated pneumonia had a significantly higher VR (n=31, median 2.192, P=0.0004). Patients with known chronic obstructive lung disease also had significantly higher VR (n=18, median 2.883, P,0.0001).
Discussion
Factors influencing VR Ventilatory efficiency
In equation (13) , if the ratio _ VCO 2actual = _ VCO 2predicted remains constant, that is, an individual in a steady state of CO 2 production, then any changes in VR would directly represent changing ventilatory efficiency or, stated otherwise, a change in the physiological deadspace ventilation. Limited data are available on the respective contributions of ventilatory efficiency and CO 2 production on changes in minute ventilation and Pa CO 2 . Ravenscraft and colleagues 9 have demonstrated that changes in ventilatory efficiency had a greater impact on 'excess' minute ventilation than changes in _ VCO 2 in critically unwell mechanically ventilated patients. In clinical practice, it is anticipated that variation in alveolar ventilation is greater than _ VCO 2 ; therefore, changes in VR would foremost represent ventilatory efficiency. CO 2 production ( _ VCO 2 ) CO 2 production is a measure of metabolic activity. 10 11 Factors influencing cellular metabolism, for example, sepsis, exercise, routine ICU interventions, altering levels of sedation, or temperature, changes would result in a change in _ VCO 2 . 11 -13 Extrinsic factors such as increased nutritional load 14 and drug administration 15 can also influence _ VCO 2 . In spontaneously breathing patients, an elevation in _ VCO 2 will manifest itself as an increase in _ V E or an increase in Pa CO 2 , or both, whereas in patients with fixed minute ventilation, elevation in _ VCO 2 levels will lead to an increase in Pa CO 2 . Both spontaneously ventilating and fixed minute ventilation groups have been shown to have reduced ventilatory efficiency and an increase in measured deadspace ventilation. 13 The full extent and impact of variation in CO 2 production in ICU patients, and the influence on VR, requires further investigation. In the absence of an obvious ventilatory cause, the evaluation of changing VR should incorporate a consideration of altered metabolism. From the mathematical model described above, it can be stated that in a patient where the ventilatory efficiency remains constant, a doubling of _ VCO 2 would result in the doubling of VR. Similarly, in a patient with constant _ VCO 2 , a halving of the alveolar ventilation would result in doubling of VR. In mechanically ventilated patients, studies have shown that although metabolically stimulating interventions can result in _ VCO 2 elevations of up to 35%, they tend to be short-lived and return to baseline levels rapidly. 12 16 Therefore, it is expected that sustained changes in VR are most likely to represent changes in ventilatory efficiency.
Right-to-left shunt
In respiratory physiology, it is widely assumed that Pa CO 2 approximates to PA CO 2 .
17 However, with this assumption, the additional effect of true shunt cannot be extracted from VR. Additionally, in critically unwell patients, PE 0 CO 2 frequently misrepresents PA CO 2 ;
18 therefore, the use of Pa CO 2 reduces the associated unquantifiable variation and having practical simplicity. The predicted effect of the right-to-left shunt is thought to be small under most circumstances. Diseases such as ARDS where there is likely to be massive ventilation -perfusion mismatch, the combined impact of deadspace ventilation and shunt on CO 2 elimination will be reflected by the ratio.
Further research is being undertaken to establish the proportional impact that each of the above-mentioned factors will exert on a changing value of VR in the critically unwell patients.
Future applications of VR
VR provides clinicians with an easily calculated numerical value that reflects changes in ventilatory efficiency, or _ VCO 2 , or both. Minute ventilation and Pa CO 2 can be measured at the bedside, and this information is currently recorded by most ICUs. Single calculations of VR will provide information on the degree of variation from the predicted values. However, the most useful application as a monitoring tool in the critical care setting would be to observe trends in VR. In particular, in patients with permissive hypercapnia, VR may be used to monitor changing underlying ventilatory efficiency. VR would also provide useful information while assessing therapeutic procedures carried out to improve alveolar ventilation. Currently, success of manoeuvres such as recruitment, bronchoscopy, and prone positioning in mechanically ventilated patients is judged on improvement in oxygenation. 19 20 Although calculation of deadspace ventilation has been shown to be a useful tool, 21 this is often difficult to carry out at the bedside. VR offers information about changes in alveolar ventilation, a parameter at the heart of the manoeuvres, and it is easy to calculate.
The value of Pa CO 2 as a prognostic indicator in ARDS has been elegantly demonstrated by Gattinoni and colleagues. 22 Physiological deadspace is also known to predict the outcome in ARDS. 23 As VR incorporates both these variables, it may be a useful prognostic indicator. We expect the Pa O 2 /FI O 2 ratio and VR to behave largely independently of one another, especially in patients who 
Previous indices and markers of ventilation
Radford 10 outlined the use of preset ventilatory standards for measuring adequacy of mechanical ventilation, but in general the comparison of 'measured' and 'predicted' parameter values is seldom used in current critical care practice. In contrast, in respiratory medicine, particularly in lung function testing, such methods of comparison are well established. 24 VR revisits this concept to reflect ventilation in the critically ill.
VR can be calculated by measuring tidal volume, ventilatory frequency, and Pa CO 2 . Previous attempts have been made to analyse these variables either individually or in combination, to develop indices to facilitate decisionmaking in mechanically ventilated patients. However, it has proved difficult to develop an objective ratio of ventilatory function that combines all three variables while being simple to calculate at the bedside. Jabour and colleagues 25 proposed a weaning ratio that combines ventilatory endurance with efficiency of gas exchange. They have defined the term 'VE40' as the predicted minute ventilation (normalized to body weight) required to bring Pa CO 2 to 40 mm Hg. They used VE40 to calculate the efficiency of gas exchange for the purpose of weaning. Although conceptually similar, VR produces a simple numerical value, offering broader applications. Other investigators have looked at minute ventilation as an aid both to managing and to weaning ventilated patients. Adaptive support ventilation (Hamilton Galileo) utilizes Otis and colleagues' 26 minimal work of breathing calculations to adjust ventilatory frequency and tidal volume to produce a target minute ventilation of 100 ml kg 21 in adult patients. 27 Although Martinez and colleagues 28 have proposed monitoring minute ventilation recovery time as a parameter for predicting successful weaning.
Yang and Tobin 29 have defined a weaning index that uses frequency/tidal volume to quantitate rapid shallow breathing. Similar to VR, f/V t is an easy to calculate index, but offers little insight into CO 2 elimination. In a study elsewhere Jubran and Tobin 30 have demonstrated that impaired CO 2 elimination results in an increase in failure to extubate in chronic obstructive pulmonary disease (COPD) patients. The product of Pa CO 2 and inspiratory pressure-time product was utilized as an index of inefficient CO 2 clearance.
In contrast to the above-mentioned studies, VR is unique because changes in its value reflect changes in both _ V E and Pa CO 2 and can be easily calculated from measured values at the bedside. In conjunction with indices that reflect work of breathing, such as f/V t , VR may be a useful tool in predicting weaning.
In summary, the VR is a novel measure of ventilatory function. By comparing measured with predicted values, VR is normalized to the individual. Changes in VR reflect changes in ventilatory efficiency and changes in _ VCO 2 . VR has a wide range of exciting potential applications in clinical practice, enhanced by the simplicity of its calculation at the bedside.
